research and development

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

  • by

Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation. PhRMA’s comments focus on the types of initiatives and efforts that could be included in a… Read More »Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

  • by

Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other supplies and increasing manufacturing capacity to get COVID-19 vaccine shots in as many arms as possible. Even… Read More »How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

Fighting variants of COVID-19

  • by

As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two vaccines have been granted Emergency Use Authorization (EUA) in the United States by the U.S. Food… Read More »Fighting variants of COVID-19

The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

  • by

Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and cures. As our industry continues to expand vaccine production and deliver medicines to patients in need, reliable IP protections… Read More »The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

Learning from history: How government price setting and other anti-innovation policies negatively impact biopharmaceutical R&D

  • by

Today, America leads the world in medical innovation because of our unique research ecosystem, but that wasn’t always the case. A new paper from NDP Analytics, “Will US Leadership in Biopharmaceutical R&D Continue? Consequences of Price Controls and Other Anti-Innovation Policies,” takes a look at… Read More »Learning from history: How government price setting and other anti-innovation policies negatively impact biopharmaceutical R&D

Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments

  • by

In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today, we’re diving deeper into CMS’s proposal to vastly expand the types of medicines that would fall… Read More »Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments

New Report: The biopharmaceutical industry’s sustained commitment to inspiring and advancing tomorrow’s STEM workforce

  • by

America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing development of new life-saving and life-improving medicines would not be possible without a robust pipeline of… Read More »New Report: The biopharmaceutical industry’s sustained commitment to inspiring and advancing tomorrow’s STEM workforce

Flu Season 2020: Why it’s time to talk to your doctor today about getting a flu shot

  • by

As America’s biopharmaceutical companies work around the clock to combat COVID-19, another virus with deadly consequences is right around the corner. The COVID-19 pandemic has led to more than 7.5 million infections and tragically more than 210,000 deaths. The influenza virus, more commonly known as… Read More »Flu Season 2020: Why it’s time to talk to your doctor today about getting a flu shot

The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions

  • by

The first Friday of October marks Manufacturing Day, an annual recognition of the critical role manufacturing industries play in powering innovation and generating jobs and economic growth for Americans. The United States is a global leader in biopharmaceutical manufacturing, providing high-wage STEM jobs, a growing… Read More »Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions

New Graphic: Public-Private collaboration fuels the U.S. biopharmaceutical ecosystem

  • by

America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. In recent years, rapid advances in scientific discovery have ushered in a new era of medicine, transforming our… Read More »New Graphic: Public-Private collaboration fuels the U.S. biopharmaceutical ecosystem

The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

The latest: What they are saying: intellectual property protections critical as we work to defeat COVID-19

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: intellectual property protections critical as we work to defeat COVID-19

Lecithin Supplements: Understanding the Risks and Benefits

Lecithin Supplements: Understanding the Risks and Benefits Before you take lecithin supplements, you should weigh the lack of credible evidence of benefits against scientific literature that suggests safety concerns. The Doctor Weighs In

The latest: What they are saying: Importance of intellectual property protections to combat COVID-19

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Importance of intellectual property protections to combat COVID-19

How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­

  • by

As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while also researching and developing new therapies to treat those infected with the virus. Given the… Read More »How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­